Does ‘heparin-induced thrombocytopenia’ hit our minds?
Unfractionated heparin is a widely used drug to prevent deep vein thrombosis and pulmonary emboli in patients at risk. With the advent of newer anticoagulants having lesser side effects, its use has diminished but not out of service. Here, we report a case of deep venous thrombosis, in a patient on...
Main Authors: | Arun R. Thangavel, Shalvi Mahajan, Amarjyoti Hazarika |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2016-08-01
|
Series: | Journal of Neuroanaesthesiology and Critical Care |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.4103/2348-0548.190071 |
Similar Items
-
Failure of Fondaparinux in Autoimmune Heparin-Induced Thrombocytopenia
by: Michelangelo Sartori, et al.
Published: (2020-10-01) -
IS THE INCIDENCE TREND OF HEPARIN-INDUCED THROMBOCYTOPENIA DECREASED BY THE INCREASED USE OF LOW-MOLECULAR-WEIGHT-HEPARIN?
by: Fahad Al-Eidan
Published: (2015-04-01) -
Fondaparinux monitoring in a patient with heparin-induced thrombocytopenia on hemodialysis
by: Kušić Jovana, et al.
Published: (2016-01-01) -
Heparin-induced thrombocytopenia
by: Shaikh Nissar
Published: (2011-01-01) -
Heparin- induced thrombocytopenia (HIT): a case report of CABG patient
by: Alireza Jahangirifard, et al.
Published: (2016-08-01)